NO20031705L - Vaksiner - Google Patents

Vaksiner

Info

Publication number: NO20031705L
Authority: NO; Norway
Prior art keywords: vaccinations
Prior art date: 2000-10-18

Application number

NO20031705A

Other languages

English (en)

Other versions

NO20031705D0 (no

NO335919B1 (no

Inventor

Nathalie Garcon

Catherine Marie Ghislai Gerard

Jean Stephenne

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-18

Filing date

2003-04-11

Publication date

2003-06-14

2000-10-18 Priority claimed from GB0025573A external-priority patent/GB0025573D0/en

2000-10-18 Priority claimed from US09/690,921 external-priority patent/US6544518B1/en

2000-10-18 Priority claimed from GB0025574A external-priority patent/GB0025574D0/en

2003-04-11 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2003-04-11 Publication of NO20031705D0 publication Critical patent/NO20031705D0/no

2003-06-14 Publication of NO20031705L publication Critical patent/NO20031705L/no

2015-03-23 Publication of NO335919B1 publication Critical patent/NO335919B1/no

Links

238000002255 vaccination Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Oncology (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20031705A 2000-10-18 2003-04-11 Immunogen sammensetning, samt anvendelse derav. NO335919B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0025573A GB0025573D0 (en)	2000-10-18	2000-10-18	Vaccine
US09/690,921 US6544518B1 (en)	1999-04-19	2000-10-18	Vaccines
GB0025574A GB0025574D0 (en)	2000-10-18	2000-10-18	Vaccine
PCT/EP2001/011984 WO2002032450A2 (en)	2000-10-18	2001-10-16	Vaccines

Publications (3)

Publication Number	Publication Date
NO20031705D0 NO20031705D0 (no)	2003-04-11
NO20031705L true NO20031705L (no)	2003-06-14
NO335919B1 NO335919B1 (no)	2015-03-23

Family

ID=27255945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031705A NO335919B1 (no)	2000-10-18	2003-04-11	Immunogen sammensetning, samt anvendelse derav.

Country Status (18)

Country	Link
EP (2)	EP1889630B1 (no)
JP (1)	JP2004511527A (no)
KR (1)	KR100860893B1 (no)
CN (1)	CN100548373C (no)
AU (2)	AU4433702A (no)
BR (1)	BR0114786A (no)
CA (1)	CA2425358C (no)
CZ (1)	CZ302449B6 (no)
DK (1)	DK1326638T3 (no)
ES (1)	ES2295229T3 (no)
HU (1)	HU229642B1 (no)
IL (1)	IL155282A0 (no)
MX (1)	MXPA03003408A (no)
NO (1)	NO335919B1 (no)
NZ (1)	NZ525320A (no)
PL (1)	PL208755B1 (no)
SI (1)	SI1326638T1 (no)
WO (1)	WO2002032450A2 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69929444T2 (de)	1998-08-10	2006-09-28	Antigenics Inc., Woburn	Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
US7776343B1 (en)	1999-02-17	2010-08-17	Csl Limited	Immunogenic complexes and methods relating thereto
CN1599623B (zh)	2001-09-14	2011-05-11	赛托斯生物技术公司	免疫刺激物向病毒样颗粒内的包装:制备方法与用途
CA2471092A1 (en)	2001-12-21	2003-07-10	Antigenics Inc.	Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
KR100456681B1 (ko)	2002-05-22	2004-11-10	주식회사 대웅	박테리아의 염색체 ｄｎａ 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
AU2003242742B2 (en) *	2002-06-20	2009-04-30	Cytos Biotechnology Ag	Packaged virus-like particles for use as adjuvants: method of preparation and use
AU2003260748A1 (en) *	2002-08-30	2004-03-19	Glaxo Group Limited	Il-14 vaccine for the treatment of asthma and atopic disorders
SG122973A1 (en)	2003-10-30	2006-06-29	Coley Pharm Gmbh	C-class oligonucleotide analogs with enhanced immunostimulatory potency
EP1781325A2 (en) *	2004-07-18	2007-05-09	CSL Limited	Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
WO2006050116A1 (en) *	2004-11-02	2006-05-11	Biomedical Research Models, Inc.	Methods of cancer treatment/prevention using cancer cell-specific surface antigens
GB0504436D0 (en) *	2005-03-03	2005-04-06	Glaxosmithkline Biolog Sa	Vaccine
US11707520B2 (en)	2005-11-03	2023-07-25	Seqirus UK Limited	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
CA2628152C (en)	2005-11-04	2016-02-02	Novartis Vaccines And Diagnostics S.R.L.	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
EP2468300B1 (en)	2006-09-26	2017-12-20	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
CA2744987C (en)	2008-12-02	2018-01-16	Chiralgen, Ltd.	Method for the synthesis of phosphorus atom modified nucleic acids
DK2396032T3 (en)	2009-02-10	2016-12-19	Seqirus Uk Ltd	Influenza vaccines with reduced amounts of squalene
CN102481312B (zh)	2009-06-05	2015-07-15	传染性疾病研究院	合成的吡喃葡萄糖脂佐剂
BR112012000828A8 (pt)	2009-07-06	2017-10-10	Ontorii Inc	Novas pró-drogas de ácido nucleico e métodos de uso das mesmas
EP2575876B1 (en)	2010-05-26	2017-12-06	Selecta Biosciences, Inc.	Multivalent synthetic nanocarrier vaccines
WO2012039448A1 (ja)	2010-09-24	2012-03-29	株式会社キラルジェン	不斉補助基
EA027236B1 (ru)	2011-04-08	2017-07-31	Иммьюн Дизайн Корп.	Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
US9605019B2 (en)	2011-07-19	2017-03-28	Wave Life Sciences Ltd.	Methods for the synthesis of functionalized nucleic acids
MX2014001142A (es)	2011-07-29	2014-02-27	Selecta Biosciences Inc	Nanoportadores sinteticos que generan respuestas inmunitarias humorales y de linfocitos t citotoxicos (ctl).
EP2751570A4 (en) *	2011-08-31	2015-08-12	Oncocyte Corp	METHOD AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER
EP3388835B1 (en)	2012-05-16	2020-04-01	Immune Design Corp.	Vaccines for hsv-2
KR101835401B1 (ko) *	2012-07-13	2018-03-08	신 니뽄 바이오메디칼 라보라토리즈, 엘티디.	키랄 핵산 어쥬번트
AU2013288048A1 (en)	2012-07-13	2015-01-22	Wave Life Sciences Ltd.	Asymmetric auxiliary group
KR20220139425A (ko)	2012-07-13	2022-10-14	웨이브 라이프 사이언시스 리미티드	키랄 제어
AU2013358892B2 (en) *	2012-12-13	2018-06-21	Aduro Biotech, Inc.	Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
EP2777711A1 (en) *	2013-03-11	2014-09-17	Icon Genetics GmbH	Her2/Neu cancer vaccine
CN105209047B (zh)	2013-04-18	2020-08-18	免疫设计股份有限公司	用于癌症治疗的gla单一疗法
SG10201708821RA (en)	2013-04-29	2017-12-28	Memorial Sloan Kettering Cancer Center	Compositions and methods for altering second messenger signaling
AP2015008700A0 (en)	2013-05-18	2015-08-31	Univ California	Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
CN109675026A (zh) *	2013-09-19	2019-04-26	硕腾服务有限责任公司	油基佐剂
WO2015108048A1 (ja)	2014-01-15	2015-07-23	株式会社新日本科学	抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10322173B2 (en)	2014-01-15	2019-06-18	Shin Nippon Biomedical Laboratories, Ltd.	Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
EP3095461A4 (en)	2014-01-15	2017-08-23	Shin Nippon Biomedical Laboratories, Ltd.	Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
PT3094728T (pt)	2014-01-16	2022-05-19	Wave Life Sciences Ltd	Desenho quiral

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8205892D0 (sv) *	1982-10-18	1982-10-18	Bror Morein	Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
UA56132C2 (uk) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
DK1659178T3 (da) *	1998-02-05	2010-07-12	Glaxosmithkline Biolog Sa	Fremgangsmåde til oprensning eller fremstilling af et MAGE-protein
DE69932717T2 (de) *	1998-05-22	2007-08-09	Ottawa Health Research Institute, Ottawa	Methoden und produkte zur induzierung mukosaler immunität
DE69929444T2 (de) *	1998-08-10	2006-09-28	Antigenics Inc., Woburn	Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
CN1201004C (zh) *	1999-01-29	2005-05-11	考丽克萨有限公司	HER－2/neu融合蛋白
WO2000062800A2 (en) *	1999-04-19	2000-10-26	Smithkline Beecham Biologicals Sa	Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
AU781812B2 (en) *	2000-01-13	2005-06-16	Antigenics, Inc.	Innate immunity-stimulating compositions of CPG and saponin and methods thereof
EP1985702A3 (en) *	2000-12-08	2010-08-18	Coley Pharmaceutical GmbH	CPG-like nucleic acids and methods of use thereof

2001
- 2001-10-16 ES ES01987671T patent/ES2295229T3/es not_active Expired - Lifetime
- 2001-10-16 CN CNB018206611A patent/CN100548373C/zh not_active Expired - Fee Related
- 2001-10-16 PL PL365598A patent/PL208755B1/pl unknown
- 2001-10-16 CZ CZ20031093A patent/CZ302449B6/cs not_active IP Right Cessation
- 2001-10-16 NZ NZ525320A patent/NZ525320A/en not_active IP Right Cessation
- 2001-10-16 WO PCT/EP2001/011984 patent/WO2002032450A2/en active IP Right Grant
- 2001-10-16 EP EP07121675A patent/EP1889630B1/en not_active Expired - Lifetime
- 2001-10-16 AU AU4433702A patent/AU4433702A/xx active Pending
- 2001-10-16 CA CA2425358A patent/CA2425358C/en not_active Expired - Fee Related
- 2001-10-16 EP EP01987671A patent/EP1326638B9/en not_active Expired - Lifetime
- 2001-10-16 SI SI200130800T patent/SI1326638T1/sl unknown
- 2001-10-16 AU AU2002244337A patent/AU2002244337B2/en not_active Ceased
- 2001-10-16 HU HU0402067A patent/HU229642B1/hu not_active IP Right Cessation
- 2001-10-16 DK DK01987671T patent/DK1326638T3/da active
- 2001-10-16 MX MXPA03003408A patent/MXPA03003408A/es active IP Right Grant
- 2001-10-16 IL IL15528201A patent/IL155282A0/xx unknown
- 2001-10-16 KR KR1020077026150A patent/KR100860893B1/ko not_active IP Right Cessation
- 2001-10-16 BR BR0114786-2A patent/BR0114786A/pt not_active IP Right Cessation
- 2001-10-16 JP JP2002535687A patent/JP2004511527A/ja active Pending
2003
- 2003-04-11 NO NO20031705A patent/NO335919B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1326638B9 (en)	2008-02-20
BR0114786A (pt)	2003-08-12
EP1326638A2 (en)	2003-07-16
ES2295229T3 (es)	2008-04-16
CN100548373C (zh)	2009-10-14
AU2002244337B2 (en)	2005-08-11
KR100860893B1 (ko)	2008-09-29
PL208755B1 (pl)	2011-06-30
CA2425358A1 (en)	2002-04-25
HUP0402067A3 (en)	2012-09-28
AU4433702A (en)	2002-04-29
EP1889630B1 (en)	2011-11-23
HUP0402067A2 (hu)	2005-01-28
WO2002032450A3 (en)	2002-10-10
IL155282A0 (en)	2003-11-23
PL365598A1 (en)	2005-01-10
EP1889630A1 (en)	2008-02-20
NO20031705D0 (no)	2003-04-11
KR20070114230A (ko)	2007-11-29
JP2004511527A (ja)	2004-04-15
CA2425358C (en)	2012-08-21
SI1326638T1 (sl)	2008-04-30
MXPA03003408A (es)	2005-06-30
EP1326638B1 (en)	2007-11-28
NO335919B1 (no)	2015-03-23
DK1326638T3 (da)	2008-03-25
HU229642B1 (en)	2014-03-28
CN1481255A (zh)	2004-03-10
WO2002032450A2 (en)	2002-04-25
CZ302449B6 (cs)	2011-05-25
CZ20031093A3 (cs)	2003-08-13
NZ525320A (en)	2004-10-29

Legal Events

Date	Code	Title	Description
2017-05-29	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20030823D0 (no)	2003-02-21	Vaksiner
NO20031705D0 (no)	2003-04-11	Vaksiner
NO20031483D0 (no)	2003-04-01	Vaksine
NO20021433D0 (no)	2002-03-21	Vaksiner
NO20024172D0 (no)	2002-09-02	Vaksine
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
DE1274523T1 (de)	2003-05-28	Hochdruckumformspülanlage
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
NO20024322D0 (no)	2002-09-10	Sekvens
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es)	2003-04-16	Antitranspirantes
DE10052925B4 (de)	2005-03-10	Schaukelbett
DE50007634D1 (de)	2004-10-07	Kardioplegieballonkatheter
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos